Literature DB >> 15695674

High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania.

Bjørn Blomberg1, Roland Jureen, Karim P Manji, Bushir S Tamim, Davis S M Mwakagile, Willy K Urassa, Maulidi Fataki, Viola Msangi, Marit G Tellevik, Samwel Y Maselle, Nina Langeland.   

Abstract

Extended-spectrum beta-lactamases (ESBLs) were present in high proportions of Escherichia coli (25% [9 of 36]) and Klebsiella pneumoniae isolates (17% [9 of 52]) causing pediatric septicemia at a tertiary hospital in Tanzania. Patients with septicemia due to ESBL-producing organisms had a significantly higher fatality rate than those with non-ESBL isolates (71% versus 39%, P = 0.039). This is the first report of the CTX-M-15 genotype of ESBLs on the African continent and the first observation of SHV-12 genotype in an isolate of Salmonella enterica serotype Newport.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15695674      PMCID： PMC548071          DOI： 10.1128/JCM.43.2.745-749.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  [Nosocomial Klebsiella pneumoniae infections at the Fann University Hospital Center, Dakar].

Authors:  A I Sow; R Diagne; M F Cisse; N M Dia; O K Sy; M Gaye; M Ndiaye; A Komo
Journal:  Dakar Med       Date:  1997

2.  Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme.

Authors:  M Gniadkowski; I Schneider; A Pałucha; R Jungwirth; B Mikiewicz; A Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

3.  Importance of organisms producing broad-spectrum SHV-group beta-lactamases into the United Kingdom.

Authors:  K P Shannon; A King; I Phillips; M H Nicolas; A Philippon
Journal:  J Antimicrob Chemother       Date:  1990-03       Impact factor: 5.790

4.  Two novel transferable extended-spectrum beta-lactamases from Klebsiella pneumoniae in Tunisia.

Authors:  S Ben Redjeb; G Fournier; C Mabilat; A Ben Hassen; A Philippon
Journal:  FEMS Microbiol Lett       Date:  1990-01-15       Impact factor: 2.742

5.  Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.

Authors:  J K Rasheed; C Jay; B Metchock; F Berkowitz; L Weigel; J Crellin; C Steward; B Hill; A A Medeiros; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

6.  A new plasmidic cefotaximase in a clinical isolate of Escherichia coli.

Authors:  A Bauernfeind; H Grimm; S Schweighart
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

7.  Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital.

Authors:  Véronique Leflon-Guibout; Cécile Jurand; Stéphane Bonacorsi; Florence Espinasse; Marie Claude Guelfi; Françoise Duportail; Beate Heym; Edouard Bingen; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

8.  Involvement of SHV-12 and SHV-2a encoding plasmids in outbreaks of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Tunisian neonatal ward.

Authors:  Thouraya Ben-Hamouda; Thierry Foulon; Kamel Ben-Mahrez
Journal:  Microb Drug Resist       Date:  2004       Impact factor: 3.431

9.  Multiple CTX-M-type extended-spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy.

Authors:  Laura Pagani; Emanuela Dell'Amico; Roberta Migliavacca; Marco Maria D'Andrea; Ernesto Giacobone; Gianfranco Amicosante; Egidio Romero; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

10.  Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France.

Authors:  C Eckert; V Gautier; M Saladin-Allard; N Hidri; C Verdet; Z Ould-Hocine; G Barnaud; F Delisle; A Rossier; T Lambert; A Philippon; G Arlet
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191
View more
  74 in total

1.  CTX-M-3 and CTX-M-15 extended-spectrum beta-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria.

Authors:  Nadjia Ramdani-Bouguessa; Nuno Mendonça; Joana Leitão; Eugénia Ferreira; Mohamed Tazir; Manuela Caniça
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

2.  Isolation of Salmonella enterica serotype newport from a partly ruptured splenic abscess in a traveler returning from Zanzibar.

Authors:  Dennis Tappe; Andreas Müller; Heinz-Jakob Langen; Matthias Frosch; August Stich
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

3.  Chromosomal integration of the extended-spectrum beta-lactamase gene blaCTX-M-15 in Salmonella enterica serotype Concord isolates from internationally adopted children.

Authors:  Laëtitia Fabre; Aurélia Delauné; Emmanuelle Espié; Karin Nygard; Maria Pardos de la Gandara; Lucette Polomack; Françoise Guesnier; Marc Galimand; Jørgen Lassen; François-Xavier Weill
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

Review 4.  Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat.

Authors:  Paul J Lukac; Robert A Bonomo; Latania K Logan
Journal:  Clin Infect Dis       Date:  2015-01-16       Impact factor: 9.079

5.  Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals.

Authors:  C M Lonchel; P Melin; J Gangoué-Piéboji; M-C O Assoumou; R Boreux; P De Mol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-11       Impact factor: 3.267

6.  Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population.

Authors:  Lakshmi Chandramohan; Paula A Revell
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

7.  Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases.

Authors:  Johann D D Pitout; Kevin B Laupland; Deirdre L Church; Megan L Menard; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

8.  Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania.

Authors:  Neema Kayange; Erasmus Kamugisha; Damas L Mwizamholya; Seni Jeremiah; Stephen E Mshana
Journal:  BMC Pediatr       Date:  2010-06-04       Impact factor: 2.125

9.  High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar.

Authors:  Todisoa Andriatahina; Frédérique Randrianirina; Eliosa Ratsima Hariniana; Antoine Talarmin; Honoré Raobijaona; Yves Buisson; Vincent Richard
Journal:  BMC Infect Dis       Date:  2010-07-12       Impact factor: 3.090

10.  Characterization of ESBL (SHV-12) producing clinical isolate of Enterobacter aerogenes from a tertiary care hospital in Nigeria.

Authors:  Murat Kasap; Kayode Fashae; Sinem Torol; Fetiye Kolayli; Fatma Budak; Haluk Vahaboglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-01-12       Impact factor: 3.944
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.